| Not Yet Recruiting | Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fi Pulmonary Fibrosis | Phase 3 | 2026-12-16 |
| Not Yet Recruiting | A Study To Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Untre Untreated Melanoma, Unresectable Melanoma, Metastatic Melanoma | Phase 4 | 2026-11-15 |
| Not Yet Recruiting | A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism Spectrum Diso Irritability Associated With Autism Spectrum Disorder | Phase 3 | 2026-09-11 |
| Not Yet Recruiting | A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism Irritability Associated With Autism Spectrum Disorder | Phase 3 | 2026-09-11 |
| Not Yet Recruiting | A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Me Solid Tumors | Phase 2 | 2026-07-17 |
| Not Yet Recruiting | A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis Arthritis, Rheumatoid | Phase 1 / Phase 2 | 2026-05-28 |
| Recruiting | A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimuma Advanced Renal Cell Carcinoma (RCC) | Phase 1 / Phase 2 | 2026-04-30 |
| Not Yet Recruiting | Asia Myelodysplastic Syndrome (MDS) Registry Myelodysplastic Syndromes (MDS) | — | 2026-03-26 |
| Recruiting | A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Partic Hepatocellular Carcinoma (HCC) | Phase 1 / Phase 2 | 2026-03-16 |
| Recruiting | A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants Wi Non-small Cell Lung Cancer (NSCLC) | Phase 3 | 2026-03-16 |
| Recruiting | A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma | Phase 2 / Phase 3 | 2026-03-13 |
| Recruiting | A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated A Non-Small Cell Lung Cancer (NSCLC) | Phase 3 | 2026-03-12 |
| Recruiting | A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Ar Rheumatoid Arthritis | Phase 1 | 2026-02-27 |
| Recruiting | Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT) Schizophrenia | — | 2026-02-26 |
| Recruiting | A Real-World Study to Evaluate Luspatercept in Adults With Transfusion-Dependent Beta-Thalassemia in the Middl β-thalassemia | — | 2026-02-26 |
| Recruiting | A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (S Systemic Lupus Erythematosus (SLE), Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) | Phase 4 | 2026-02-24 |
| Recruiting | A Study to Evaluate the Effect of BMS-986278 on Cardiac Repolarization in Healthy Participants Healthy Volunteers | Phase 1 | 2026-02-19 |
| Recruiting | A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination With Nivolumab in Partici Relapsed/Refractory Small Cell Lung Cancer | Phase 1 / Phase 2 | 2026-02-03 |
| Active Not Recruiting | A Study of Incidence, Treatment Patterns, and Outcomes in Transfusion-dependent Lower-risk Myelodysplastic Syn Lower-risk Myelodysplastic Syndromes (TD LR-MDS) | — | 2026-02-02 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGE Schizophrenia | Phase 3 | 2026-01-29 |
| Recruiting | Effectiveness of Ozanimod in Patients With Steroid-Dependent Ulcerative Colitis Ulcerative Colitis (UC) | — | 2026-01-29 |
| Recruiting | A Study to Evaluate the Effect of KarXT on Urological Safety Schizophrenia | Phase 4 | 2026-01-20 |
| Recruiting | A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC) Renal Cell Carcinoma | Phase 1 | 2026-01-15 |
| Recruiting | A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic C Hypertrophic Cardiomyopathy | — | 2026-01-15 |
| Recruiting | A Study to Compare the Combination of BMS-986504 With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembr Metastatic Non-small Cell Lung Cancer With MTAP Deletion | Phase 2 / Phase 3 | 2026-01-02 |
| Recruiting | A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab i Untreated, Unresectable, or Metastatic Colorectal Cancer | Phase 2 / Phase 3 | 2025-12-31 |
| Completed | Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates Healthy Volunteers | Phase 1 | 2025-12-31 |
| Recruiting | A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986521 in Healthy Participants. Healthy Volunteers | Phase 1 | 2025-12-23 |
| Not Yet Recruiting | A Study to Assess the Drug Levels and Safety of BMS-986435 in Participants With Normal Hepatic Function and Pa Healthy Volunteers, Hepatic Impairment | Phase 1 | 2025-12-15 |
| Active Not Recruiting | Effectiveness and Safety of ONUREG (Oral Azacitidine) in Chinese Patients With Acute Myeloid Leukemia Acute Myeloid Leukemia (AML) | — | 2025-12-09 |
| Recruiting | A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Partic Plaque Psoriasis | Phase 3 | 2025-12-03 |
| Not Yet Recruiting | A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring Ulcerative Colitis | — | 2025-12-03 |
| Recruiting | A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease Alzheimer Disease, Agitation | Phase 3 | 2025-12-02 |
| Completed | Real-World Outcomes of First-Line Nivolumab + Ipilimumab With Chemotherapy in Non-Small Cell Lung Cancer in Po Non-Small Cell Lung Cancer | — | 2025-12-01 |
| Recruiting | A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Ca Advanced Solid Malignancies, Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) | Phase 1 / Phase 2 | 2025-11-25 |
| Withdrawn | A Lactation Study in Women Receiving Treatment With Ozanimod Lactating Women, Breastfed Infants | Phase 4 | 2025-11-15 |
| Recruiting | A Study to Assess the Relative Bioavailability of BMS-986435 and Food Effect on the BMS-986435 in Healthy Adul Healthy Volunteers | Phase 1 | 2025-11-12 |
| Completed | A Study to Assess the Effect of Food on the Drug Levels of Admilparant Healthy Participants | Phase 1 | 2025-11-07 |
| Recruiting | Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Non-Small Cell Lung Cancer | Phase 2 / Phase 3 | 2025-11-05 |
| Recruiting | A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination Pancreatic Ductal Adenocarcinoma | Phase 2 / Phase 3 | 2025-10-23 |
| Recruiting | A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors Solid Tumours | Phase 1 / Phase 2 | 2025-10-15 |
| Recruiting | A Study to Assess Safety, Tolerability and Drug Levels of BMS-986504 in Participants With Advanced Solid Tumor Advanced Solid Tumors | Phase 1 | 2025-10-15 |
| Recruiting | A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids a Systemic Lupus Erythematosus (SLE) | — | 2025-10-08 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mi Mania, Bipolar Disorder | Phase 3 | 2025-10-08 |
| Recruiting | Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer Wit Urothelial Cancer | Phase 2 / Phase 3 | 2025-09-30 |
| Recruiting | Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU) Schizophrenia | — | 2025-09-22 |
| Recruiting | Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK) Plaque Psoriasis | Phase 3 | 2025-09-22 |
| Recruiting | A Study to Evaluate Two Dosing Regimens of Subcutaneous Nivolumab in Combination With Intravenous Ipilimumab a Non-Small Cell Lung Cancer | Phase 2 | 2025-09-19 |
| Recruiting | A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Adva Breast Neoplasms | Phase 2 / Phase 3 | 2025-09-11 |
| Recruiting | A Study of BMS-986504 in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCL Carcinoma, Non-Small-Cell Lung | Phase 2 | 2025-09-09 |
| Recruiting | A Study of Mavacamten in Adults With Obstructive Hypertrophic Cardiomyopathy in India (ROVER) Symptomatic Obstructive Hypertrophic Cardiomyopathy | Phase 4 | 2025-09-04 |
| Recruiting | A Study to Evaluate the Dose Levels, Safety, and Drug Levels of Single KarXT Intramuscular Injection in Partic Schizophrenia | Phase 1 | 2025-09-03 |
| Recruiting | Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy Psoriasis | — | 2025-08-05 |
| Recruiting | A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors Advanced Solid Tumor, Advanced Breast Cancer, Advanced Ovarian Cancer | Phase 1 | 2025-08-01 |
| Not Yet Recruiting | A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzhei Alzheimer Disease, Psychosis | Phase 3 | 2025-07-31 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease Alzheimer's Disease | Phase 3 | 2025-07-21 |
| Recruiting | A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BAL Bipolar Disorder Type I With Mania | Phase 3 | 2025-07-18 |
| Recruiting | A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associat Alzheimer Disease | Phase 3 | 2025-07-16 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease Alzheimer's Disease | Phase 3 | 2025-07-14 |
| Recruiting | A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associat Alzheimer Disease | Phase 3 | 2025-07-10 |
| Recruiting | A Study to Evaluate Novel KarX and KarT Prototypes Versus the KarXT and KarX-EC Reference Following Single Dos Healthy Volunteers | Phase 1 | 2025-06-27 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder Bipolar Disorder Type I With Mania or Mania With Mixed Features | Phase 3 | 2025-06-13 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder Bipolar-I Disorder With Mania or Mania With Mixed Features | Phase 3 | 2025-06-11 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of KarXT in Acutely Psychotic Japanese Adult Participants With Sch Schizophrenia | Phase 3 | 2025-06-10 |
| Completed | A Study Describing Real-World Effectiveness of Nivolumab + Chemotherapy in Neoadjuvant NSCLC Non-small Cell Lung Cancer (NSCLC) | — | 2025-05-26 |
| Recruiting | Mavacamten Post-marketing Surveillance in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan Obstructive Hypertrophic Cardiomyopathy (oHCM) | — | 2025-05-21 |
| Recruiting | Patient Reported Outcomes and Patient Voice Among Patients Diagnosed With Low Risk Myelodysplastic Syndrome (L Myelodysplastic Syndrome (MDS) | — | 2025-05-13 |
| Completed | Real-world Outcomes Among Patients With Melanoma Treated With Neoadjuvant Nivolumab+Relatlimab or Nivolumab+Ip Melanoma | — | 2025-05-11 |
| Active Not Recruiting | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BMS-986489 in Chin Small Cell Lung Carcinoma | Phase 1 | 2025-05-07 |
| Completed | A Study to Assess Drug Levels, Tolerability and Absolute Biological Availability of Single-dose of BMS-986446 Healthy Volunteer | Phase 1 | 2025-05-05 |
| Completed | Safety, Tolerability, and Pharmacokinetics of KarXT and Dual-burst Release of Xanomeline With Immediate-releas Psychiatric Disorders | Phase 1 | 2025-04-29 |
| Active Not Recruiting | Treatment Patterns and Outcomes in Patients With Lower-risk Myelodysplastic Syndromes Treated With Luspatercep Myelodysplastic Syndromes | — | 2025-04-18 |
| Active Not Recruiting | A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors Advanced Malignant Tumors | Phase 1 | 2025-03-25 |
| Recruiting | A Study to Evaluate the Mass Balance, Metabolism, Elimination, and Drug Levels of [14C]-BMS-986504 (MRTX1719) Advanced Solid Tumors With Homozygous MTAP Deletion | Phase 1 | 2025-03-24 |
| Recruiting | A Study to Assess Deucravacitinib Safety in Pregnancy Psoriasis (PsO) | — | 2025-03-21 |
| Completed | A Single-dose Study to Evaluate the Safety, Tolerability, Drug Levels, and Relative Biological Availability of Healthy Volunteers | Phase 1 | 2025-03-19 |
| Recruiting | A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Partici Juvenile Psoriatic Arthritis | Phase 3 | 2025-03-13 |
| Completed | A Study to Investigate the Safety, Tolerability, and Drug Levels of BMS-986419 (Part 1) and the Effects Multip Healthy Volunteers | Phase 1 | 2025-02-27 |
| Recruiting | A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Com Extensive-Stage Small Cell Lung Cancer | Phase 3 | 2025-02-25 |
| Recruiting | A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 / Phase 2 | 2025-02-17 |
| Recruiting | A Study of BMS-986490 With or Without Bevacizumab in Advanced Solid Tumors Advanced Solid Tumors | Phase 1 / Phase 2 | 2025-02-12 |
| Completed | A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of BMS-986278 and the Effects of BMS-986 Healthy Volunteers | Phase 1 | 2025-02-10 |
| Recruiting | A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations Lung Cancer, Breast Cancer | Phase 1 / Phase 2 | 2025-02-04 |
| Recruiting | A Real-world Study to Evaluate the Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in France Psoriasis | — | 2025-01-29 |
| Active Not Recruiting | A Study Comparing the Risk of Serious Infections and Malignancies With Deucravacitinib or Biologics in Japanes Psoriasis | — | 2025-01-24 |
| Completed | A Study to Evaluate the Bioequivalence Between Immediate Release Tablets and Minitablets of Deucravacitinib (B Healthy Participants | Phase 1 | 2025-01-23 |
| Active Not Recruiting | A Observational Study to Evaluate Deucravacitinib in Patients With Moderate Plaque Psoriasis in China Plaque Psoriasis | — | 2025-01-20 |
| Completed | A Study to Evaluate Comparative Bioavailability of BMS-986278 in Healthy Participants Healthy Volunteers | Phase 1 | 2024-12-12 |
| Active Not Recruiting | Observational Study of Patients Treated With Nivolumab and Chemotherapy for Advanced or Metastatic Esophageal, Gastric Adenocarcinoma, Gastro-esophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma (EAC) | — | 2024-12-10 |
| Completed | A Study to Evaluate BMS-986278 in Participants With Normal Renal Function, Severe Renal Impairment, or End-Sta Kidney Failure, Chronic, Healthy Volunteers, Renal Impairment | Phase 1 | 2024-12-07 |
| Completed | Retrospective Evaluation of Nivolumab in Adjuvant Esophageal Cancer/Gastroesophageal Junction Cancer Esophageal Cancer, Gastroesophageal Junction Cancer | — | 2024-12-03 |
| Withdrawn | A Retrospective Study to Describe Real-World Treatment Patterns and Clinical Outcomes Among Patients With Myel Myelodysplastic Syndromes (MDS) | — | 2024-11-30 |
| Completed | Outcomes of Nivolumab in Combination With Relatlimab in Patients With Advanced Melanoma in the Flatiron Databa Advanced Melanoma | — | 2024-11-29 |
| Recruiting | Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer Treatments Non-small Cell Lung Cancer (NSCLC) | — | 2024-11-25 |
| Active Not Recruiting | Long-Term Safety Outcomes and First-Line Treatment Patterns in Patients With Non-Small Cell Lung Cancer and Pr Non-small Cell Lung Cancer (NSCLC) | — | 2024-11-22 |
| Active Not Recruiting | A Study to Evaluate Treatment Patterns and Effectiveness of Luspatercept Myelodysplastic Syndromes (MDS) | — | 2024-11-22 |
| Completed | A Study to Evaluate Treatment Patterns, Outcomes, and Healthcare Resource Utilization in Patients With Lower-R Myelodysplastic Syndromes | — | 2024-11-01 |
| Active Not Recruiting | Long-term Outcomes Among Patients With Programmed Death-ligand 1 <1% Metastatic Non-small Cell Lung Cancer Tre Metastatic Non-small Cell Lung Cancer | — | 2024-10-24 |
| Active Not Recruiting | A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2024-10-10 |
| Completed | Study to Evaluate Drug Levels of Various Solid Gastro-retentive Formulations of Deucravacitinib (BMS-986165) i Healthy Participants | Phase 1 | 2024-10-07 |
| Recruiting | A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemothera Non-small Cell Lung Cancer | Phase 3 | 2024-10-07 |
| Completed | A Study to Assess the Extent of Drug Interaction Between BMS-986278 and Nintedanib, the Relative Bioavailabili Healthy Participants | Phase 1 | 2024-09-19 |
| Recruiting | A Study to Evaluate the Long-Term Safety of Idecabtagene Vicleucel Treatment in Adults With Newly Diagnosed Mu Multiple Myeloma | — | 2024-09-11 |
| Recruiting | A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants W High-grade Serous Ovarian Carcinoma (HGSOC), Uterine Serous Carcinoma (USC), Non-small Cell Lung Cancer (NSCLC) | Phase 1 | 2024-09-06 |
| Completed | Clinical Outcomes of Patients With Resectable Non-Small Cell Lung Cancer Receiving Neoadjuvant Nivolumab Plus Non-small Cell Lung Cancer (NSCLC) | — | 2024-09-05 |
| Completed | Study to Assess Relative Bioavailability of BMS-986435 Formulations in Healthy Adult Participants Healthy Participants | Phase 1 | 2024-09-03 |
| Completed | A Study to Assess the Effect of Voriconazole and Quinidine on the Pharmacokinetics of a Single Dose of Repotre Healthy Volunteers | Phase 1 | 2024-08-26 |
| Active Not Recruiting | A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Ulcerative Colitis and Thei Ulcerative Colitis | — | 2024-08-26 |
| Completed | A Study to Evaluate Luspatercept Treatment Patterns and Outcomes in Erythropoiesis-Stimulating Agents-Naïve Pa Myelodysplastic Syndromes | — | 2024-08-22 |
| Active Not Recruiting | A Real-World Study of β-Thalassemia Major Treatment With Luspatercept in Taiwan β-Thalassemia Major | — | 2024-08-21 |
| Recruiting | Real-World Safety and Effectiveness of Sotyktu (Deucravacitinib) in Patients With Moderate-to-Severe Plaque Ps Moderate-to-severe Plaque Psoriasis | — | 2024-08-21 |
| Active Not Recruiting | A Study on the Safety of Deucravacitinib Exposure in Pregnant Women and Their Offspring Psoriasis | — | 2024-08-02 |
| Terminated | Observational Study of Muscle Invasive Urothelial Carcinoma Participants Treated With Adjuvant Nivolumab in Fr Urothelial Carcinoma | — | 2024-07-30 |
| Recruiting | A Study to Assess the Safety of Mavacamten in Korean Patients With Symptomatic Obstructive Hypertrophic Cardio Obstructive Hypertrophic Cardiomyopathy | — | 2024-07-24 |
| Recruiting | A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease Anemia, Sickle Cell, Healthy Volunteers | Phase 1 / Phase 2 | 2024-07-17 |
| Terminated | A Study to Evaluate CC-486/Onureg in Participants With Moderate or Severe Hepatic Impairment Compared With Nor Hepatic Insufficiency, Neoplasms | Phase 1 | 2024-07-12 |
| Completed | A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of Single Doses of BMS-986435 (MYK Healthy Volunteers | Phase 1 | 2024-06-27 |
| Completed | Real-World Effectiveness of Mavacamten in Canada Obstructive Hypertrophic Cardiomyopathy (oHCM) | — | 2024-06-24 |
| Completed | A Study Evaluating Deucravacitinib Concentrations in the Breast Milk and Plasma of Healthy Lactating Female Pa Healthy Volunteers | Phase 4 | 2024-06-24 |
| Completed | Study to Assess Drug Levels and Safety of BMS-986278 in Healthy Participants and Participants With Different D Hepatic Impairment, Healthy Participants | Phase 1 | 2024-06-10 |
| Recruiting | Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoc Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 1 | 2024-05-29 |
| Active Not Recruiting | A Study to Assess the Effectiveness and Safety of Ozanimod in Chinese Adults With Relapsing Multiple Sclerosis Relapsing Multiple Sclerosis | Phase 4 | 2024-05-15 |
| Recruiting | Real-world Patient Reported Outcomes Among Patients Treated With Camzyos Obstructive Hypertrophic Cardiomyopathy | — | 2024-05-10 |
| Completed | A Study to Assess the Drug Levels of Repotrectinib in Healthy Participants and Participants With Moderate and Hepatic Impairment, Healthy Volunteers | Phase 1 | 2024-04-29 |
| Active Not Recruiting | A Retrospective Cohort Study of Mavacamten Patient Support Program in Canada Hypertrophic Cardiomyopathy | — | 2024-04-20 |
| Recruiting | A Post-Marketing Surveillance Study to Assess Safety of Ozanimod in Patients With Moderate to Severe Active UC Ulcerative Colitis | — | 2024-04-19 |
| Active Not Recruiting | A Study to Evaluate Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy Cardiomyopathy, Hypertrophic | Phase 3 | 2024-04-17 |
| Completed | Observational Study in Japanese Patients With Peripheral T-Cell Lymphoma Who Received Second-Line Therapy Peripheral T-cell Lymphoma | — | 2024-04-05 |
| Recruiting | A Post-Marketing Surveillance Study to Assess Safety of Luspatercept in Korean Patients With Myelodysplastic S Myelodysplastic Syndrome, Beta Thalassemia | — | 2024-03-25 |
| Active Not Recruiting | Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) Alzheimer Disease, Early Onset | Phase 2 | 2024-03-20 |
| Completed | A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986326 in Participants With Dermatitis, Atopic | Phase 1 | 2024-03-06 |
| Completed | A Study to Evaluate Nivolumab in Patients With Unresectable Advanced/Metastatic Gastric Cancer and Gastroesoph Gastric Cancer, Gastroesophageal Junction Cancer | — | 2024-02-28 |
| Completed | Real-World Outcomes of Nivolumab+Ipilimumab and Pembrolizumab+Lenvatinib Among US Advanced Renal Cell Carcinom Advanced Renal Cell Carcinoma (aRCC) | — | 2024-02-19 |
| Terminated | A Study to Evaluate the Safety, Tolerability, Drug Levels, Food, Formulation, and pH Effects on Relative Absor Healthy Participants | Phase 1 | 2024-01-29 |
| Active Not Recruiting | A Study to Evaluate Mavacamten Impact on Myocardial Structure in Participants With Symptomatic Obstructive Hyp Cardiomyopathy, Hypertrophic | Phase 4 | 2024-01-24 |
| Recruiting | A Study of the Comparative Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in Japan (RePhlect Plaque Psoriasis | — | 2024-01-22 |
| Completed | A Study to Assess the Relative Bioavailability of 5 mg Mavacamten Opened Capsule Administered Via Nasogastric Healthy Volunteers | Phase 1 | 2024-01-10 |
| Recruiting | A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hod Relapsed/Refractory Non-Hodgkin Lymphoma | Phase 1 / Phase 2 | 2023-12-29 |
| Active Not Recruiting | A Study to Assess the Treatment of Obstructive Hypertrophic Cardiomyopathy (oHCM) With Mavacamten in the US Obstructive Hypertrophic Cardiomyopathy (oHCM) | — | 2023-12-22 |
| Completed | A Study to Evaluate the Safety of Empliciti® (Elotuzumab) When Treating Patients With Multiple Myeloma in Taiw Relapsed or Refractory Multiple Myeloma | — | 2023-12-22 |
| Completed | Real-World Practice Patterns and Outcomes of Lower-Risk Myelodysplastic Syndrome Patients in Japan Lower-risk Myelodysplastic Syndromes | — | 2023-12-22 |
| Active Not Recruiting | A Study of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Carcinoma, Non-Small-Cell Lung | Phase 3 | 2023-12-21 |
| Completed | A Study to Assess Health-Related Quality of Life in Patients With Hypertrophic Cardiomyopathy in Japan Hypertrophic Cardiomyopathy | — | 2023-12-06 |
| Completed | DeteCtiON and Stroke PreventIon by MoDEl ScRreenING for Atrial Fibrillation Atrial Fibrillation, Atrial Flutter | N/A | 2023-12-04 |
| Active Not Recruiting | COLLIGO-HCM: A Multinational Observational Study of the Real-World Effectiveness of Mavacamten Among Patients Hypertrophic Cardiomyopathy (HCM) | — | 2023-12-01 |
| Recruiting | An Observational Study to Evaluate Neoadjuvant Nivolumab (OPDIVO®) in Combination With Platinum-Based Chemothe Resectable Non-small Cell Lung Cancer | — | 2023-11-30 |
| Terminated | A Study of BMS-986315 and Nivolumab in Combination With Chemotherapy in Participants With First-line Stage IV NSCLC | Phase 2 | 2023-11-27 |
| Active Not Recruiting | A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participa Relapsed or Refractory T-cell Lymphomas | Phase 1 / Phase 2 | 2023-11-20 |
| Completed | A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986454 in Healthy Participants Healthy Participants | Phase 1 | 2023-11-16 |
| Recruiting | A Post-Marketing Surveillance Study to Assess the Safety of Oral Azacitidine Maintenance Therapy in Korean Pat Acute Myeloid Leukemia | — | 2023-11-15 |
| Terminated | A Study of BMS-986466 With Adagrasib With or Without Cetuximab in Participants With Kirsten Rat Sarcoma Virus Advanced Solid Tumors | Phase 1 / Phase 2 | 2023-11-09 |
| Recruiting | Mavacamten Pregnancy Surveillance Program Breastfeeding, Hypertrophic Cardiomyopathy, Pregnancy Related | — | 2023-11-09 |
| Recruiting | Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failur Heart Failure | Phase 2 | 2023-11-07 |
| Active Not Recruiting | A Study to Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Ni Melanoma | Phase 2 | 2023-11-06 |
| Completed | A Study to Evaluate the Drug Levels, Metabolism, and Removal of BMS-986322 in Healthy Adult Male Participants Healthy Male Participants | Phase 1 | 2023-10-31 |
| Active Not Recruiting | A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulm Progressive Pulmonary Fibrosis | Phase 3 | 2023-10-25 |
| Recruiting | ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic S Myelodysplastic Syndromes | Phase 3 | 2023-10-24 |
| Recruiting | A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer Metastatic Castration-resistant Prostate Cancer | Phase 1 | 2023-10-18 |
| Completed | A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986446 in Healthy Participants and Healthy Healthy Participants | Phase 1 | 2023-10-12 |
| Active Not Recruiting | A Study to Evaluate First-line Ipilimumab + Nivolumab in Patients With Locally Advanced or Metastatic Non-Smal Non-small Cell Lung Cancer (NSCLC) | — | 2023-10-11 |
| Terminated | A Study to Evaluate Effectiveness and Safety of Deucravacitinib in Participants With Non-Pustular Palmoplantar Palmoplantar Psoriasis, Genital Psoriasis | Phase 4 | 2023-10-09 |
| Recruiting | Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufacture Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukaemia, Multiple Myeloma | — | 2023-10-06 |
| Active Not Recruiting | A Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants Myelodysplastic Syndromes | Phase 3 | 2023-10-05 |
| Completed | Incidence of Hyperpigmentation in Black Patients With Multiple Myeloma Treated With Immunomodulatory Drugs Multiple Myeloma | — | 2023-10-01 |
| Withdrawn | A Study to Evaluate the Effect of Food on the Drug Levels of BMS-986196 in Healthy Adult Participants Healthy Adult Volunteers | Phase 1 | 2023-09-22 |
| Recruiting | A Study to Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participa Lupus | Phase 1 | 2023-09-21 |
| Active Not Recruiting | A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmo Idiopathic Pulmonary Fibrosis | Phase 3 | 2023-09-14 |
| Active Not Recruiting | A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome Sjögren's Syndrome | Phase 3 | 2023-09-11 |
| Completed | A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv Healthy Volunteers | Phase 1 | 2023-09-05 |
| Completed | Real-World Use of Nivolumab for the Treatment of Patients With Metastatic Upper Gastrointestinal Cancer in Can Upper Gastrointestinal Cancer | — | 2023-09-05 |
| Completed | Real-World Use of Adjuvant Nivolumab in Patients With Upper Gastrointestinal Cancer in Canada Upper Gastrointestinal Cancer | — | 2023-09-05 |
| Completed | A Study to Evaluate Satisfaction With Care in Patients With Cancer Receiving Immunotherapy Treatment at Home Cancer, Solid Tumors | — | 2023-08-29 |
| Terminated | A Study to Evaluate the Efficacy, Safety, and Drug Levels of Oral Ozanimod in Pediatric Participants With Mode Crohn Disease | Phase 2 / Phase 3 | 2023-08-22 |
| Completed | A Study to Investigate the Effects of BMS-986278 on Drospirenone and Ethinyl Estradiol Drug Levels in Healthy Healthy Volunteers | Phase 1 | 2023-08-18 |
| Completed | A Study to Evaluate the Drug Levels of Abatacept Converted From Drug Substance by Two Different Processes in H Healthy Participants | Phase 1 | 2023-08-18 |
| Completed | A Study to Evaluate the Drug Levels, Physical and Chemical Changes, and Removal of BMS-986196 in Healthy Male Healthy Male Volunteers | Phase 1 | 2023-08-17 |
| Completed | A Study to Assess the Effect of Danicamtiv on the Drug Levels of Midazolam in Participants With Stable Heart F Heart Failure With Reduced Ejection Fraction | Phase 1 | 2023-08-17 |
| Completed | A Study to Evaluate Treatment With Nivolumab Alone and Nivolumab Combined With Ipilimumab in Children With Mel Melanoma | — | 2023-08-14 |
| Completed | A Study to Assess the Bioavailability and Effect of Food of BMS-986419 Immediate-release Tablet Formulation in Healthy Volunteers | Phase 1 | 2023-08-08 |
| Terminated | A Study to Evaluate Nivolumab in the Treatment of Early Stage Esophageal or Gastroesophageal Cancer Esophageal Carcinoma, Gastroesophageal Junction Carcinoma | — | 2023-08-04 |
| Completed | A Study to Describe the Switching From a First- or Second-line Disease Modifying Therapy (DMT) to Ozanimod in Multiple Sclerosis, Relapsing-Remitting | — | 2023-07-14 |
| Completed | A Study to Assess the Effect of Multiple Doses of Itraconazole, Gemfibrozil, or Carbamazepine on BMS-986278 in Healthy Participants | Phase 1 | 2023-07-12 |
| Recruiting | A Study to Assess the Effect of Famotidine on the Drug Levels of Afimetoran in Healthy Participants Healthy Volunteers | Phase 1 | 2023-07-04 |
| Completed | A Study to Assess the Effect of BMS-986419 on the Single Dose Drug Levels of Probe Substrates in Healthy Parti Healthy Volunteers | Phase 1 | 2023-06-29 |
| Recruiting | A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Ce Multiple Myeloma | Phase 3 | 2023-06-22 |
| Completed | A Study to Assess the Effect of Phenytoin on the Drug Levels of Afimetoran and the Effect of Afimetoran on the Healthy Participants | Phase 1 | 2023-06-14 |
| Active Not Recruiting | A Study to Describe the Persistence With Ozanimod Treatment in Relapsing-Remitting Multiple Sclerosis (RRMS) P Relapsing-remitting Multiple Sclerosis (RRMS) | — | 2023-06-14 |
| Recruiting | A Post-Marketing Surveillance Study to Assess the Safety of Fedratinib in Korean Patients With Myelofibrosis Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis | — | 2023-06-13 |
| Active Not Recruiting | A Study of BMS-986449 With and Without Nivolumab in Participants With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 / Phase 2 | 2023-06-06 |
| Completed | A Study to Evaluate the Drug-drug Interaction of BMS-986196 With Oral Contraceptives in Healthy Female Partici Healthy Female Volunteers | Phase 1 | 2023-06-06 |
| Active Not Recruiting | A Study to Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of Transfusion-dependent (T Anemia | Phase 4 | 2023-06-05 |
| Completed | A Study to Evaluate the Drug-drug Interaction Potential of BMS-986196 in Healthy Participants Healthy Volunteers | Phase 1 | 2023-05-31 |
| Withdrawn | A Study of Nivolumab Intravenous (IV) to Subcutaneous (SC) Switch in Adjuvant Melanoma and Bladder Cancer Melanoma, Urothelial Carcinoma | Phase 2 | 2023-05-31 |
| Completed | A Study to Evaluate Treatment Preferences for Japanese Participants With Muscle-invasive Urothelial Carcinoma Urinary Bladder Neoplasms | — | 2023-05-31 |
| Completed | Characteristics and Outcomes of Acute Myeloid Leukemia (AML) Patients Treated With Oral-Azacitidine Maintenanc Acute Myeloid Leukemia (AML) | — | 2023-05-23 |
| Completed | A Study to Compare the Relative Bioavailability of Two Iberdomide (CC-220) Formulations and to Assess The Effe Healthy Volunteers | Phase 1 | 2023-05-18 |
| Completed | A Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]BMS-986419 in Healthy Male Participants Healthy Volunteers | Phase 1 | 2023-05-05 |
| Active Not Recruiting | A Study to Evaluate Deucravacitinib in Participants With Moderate-to-Severe Plaque Psoriasis in Germany Plaque Psoriasis | — | 2023-04-13 |
| Active Not Recruiting | A Rollover Study of CC-122 Non-Hodgkin Lymphoma | Phase 1 | 2023-04-11 |
| Completed | A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986325 in Healthy Japanese Healthy Volunteers | Phase 1 | 2023-04-10 |
| Completed | A Study to Evaluate Effectiveness and Safety of BMS-986322 in Participants With Moderate-to-Severe Psoriasis Psoriasis | Phase 2 | 2023-04-03 |
| Completed | A Study to Evaluate the Safety, Tolerability, and Drug Levels of Danicamtiv in Healthy Japanese and Caucasian Healthy Volunteers | Phase 1 | 2023-03-31 |
| Completed | A Study to Evaluate the Drug Levels, Safety, and Tolerability of BMS-986278 in Healthy Chinese Participants Healthy Volunteers | Phase 1 | 2023-03-29 |
| Completed | A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986447 in Healthy Participants Healthy Participants | Phase 1 | 2023-03-10 |
| Active Not Recruiting | A Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination (FDC) in Previously Untreated Metastatic Melanoma | Phase 3 | 2023-03-06 |
| Completed | Mavacamten in Obstructive Hypertrophic Cardiomyopathy Obstructive Hypertrophic Cardiomyopathy (oHCM) | — | 2023-02-21 |
| Completed | A Study to Evaluate the Effects of Mavacamten in Healthy Participants Healthy Participants | Phase 1 | 2023-02-20 |
| Completed | A Study of Mezigdomide in Healthy Participants and Participants With Hepatic Impairment Hepatic Impairment | Phase 1 | 2023-02-20 |
| Completed | A Study to Evaluate the Safety and Tolerability of Cendakimab in Chinese Healthy Participants Healthy Participants | Phase 1 | 2023-02-15 |
| Completed | A Study of MORAb-202 Versus Investigator's Choice Chemotherapy in Female Participants With Platinum-resistant Neoplasms, Ovarian | Phase 2 | 2023-02-01 |
| Completed | A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in Psoriasis | Phase 4 | 2023-01-31 |
| Terminated | A Study to Evaluate the Efficacy, Safety, and Tolerability of MYK-224 in Participants With Symptomatic Obstruc Cardiomyopathy, Hypertrophic | Phase 2 | 2023-01-18 |
| Completed | A Study to Evaluate the Absorption, Metabolism, and Excretion (ADME) of BMS-986435 Healthy Volunteers | Phase 1 | 2023-01-16 |
| Active Not Recruiting | A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Activ Systemic Lupus Erythematosus | Phase 3 | 2023-01-12 |
| Active Not Recruiting | A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Particip Systemic Lupus Erythematosus | Phase 3 | 2023-01-12 |
| Active Not Recruiting | A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib Relapsed or Refractory Multiple Myeloma | Phase 3 | 2023-01-10 |
| Withdrawn | A Study of Absorption, Metabolism, and Elimination CC-90010 in Participants With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2023-01-09 |
| Completed | A Study to Assess the Effects on the Single-Dose Drug Levels of Mavacamten in Healthy Participants Healthy Participants | Phase 1 | 2023-01-06 |
| Completed | A Study Investigating the Safety, Tolerability, Drug Levels and Drug Effect of BMS-986278 in Healthy Adult Par Healthy Participants | Phase 1 | 2023-01-03 |
| Terminated | An Open-label Study of Ozanimod in Moderate to Severe Ulcerative Colitis in Clinical Practice Colitis, Ulcerative | Phase 4 | 2022-12-16 |
| Active Not Recruiting | A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care (BSC) Versus Placebo Myelodysplastic Syndromes | Phase 2 / Phase 3 | 2022-12-14 |
| Completed | A Study of Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy Cardiomyopathy, Hypertrophic | Phase 3 | 2022-12-14 |
| Terminated | A Study to Evaluate Efficacy and Long-term Safety of Oral Ozanimod in Chinese Participants With Moderately to Ulcerative Colitis | Phase 3 | 2022-12-09 |
| Completed | A Study of BMS-986360/CC-90001 Alone and in Combination With Chemotherapy or Nivolumab in Advanced Solid Tumor Advanced Solid Tumors | Phase 1 | 2022-12-09 |
| Recruiting | A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety Anemia | Phase 2 | 2022-12-09 |
| Completed | A Study to Assess Deucravacitinib Post-marketing Surveillance in Participants With Psoriasis in Japan Psoriasis | — | 2022-12-05 |
| Active Not Recruiting | A Study to Evaluate Nivolumab in Japanese Participants With Muscle-invasive Urothelial Carcinoma Muscle-invasive Urothelial Carcinoma | — | 2022-11-23 |
| Terminated | A Study of MORAb-202 in Participants With Previously Treated Metastatic Non-Small Cell Lung Cancer (NSCLC) Ade Carcinoma, Non-Small-Cell Lung | Phase 2 | 2022-11-14 |
| Completed | A Study Investigating Interactions Between BMS-986322 and Rosuvastatin, Metformin and Methotrexate in Healthy Healthy Participants | Phase 1 | 2022-11-11 |
| Terminated | A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Alopecia Areata Alopecia Areata | Phase 2 | 2022-11-08 |
| Completed | A Study to Assess Treatment Patterns, Clinical Outcomes and Healthcare Resource Utilization Among Adult Partic Psoriasis | — | 2022-10-31 |
| Completed | A Study to Investigate the Interaction of BMS-986322 and a Combined Oral Hormonal Contraceptive (Ethinyl Estra Healthy Participants | Phase 1 | 2022-10-21 |
| Completed | A Study to Evaluate the Metabolism and Excretion of BMS-986369 in Healthy Male Participants Healthy Participants | Phase 1 | 2022-10-20 |
| Recruiting | A Study of Nivolumab, Ipilimumab, and Chemotherapy in Participants With Non-small Cell Lung Cancer Carcinoma, Non-Small-Cell Lung | — | 2022-10-19 |
| Recruiting | A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other T Multiple Myeloma | Phase 1 / Phase 2 | 2022-10-18 |
| Active Not Recruiting | A Study to Evaluate Luspatercept (ACE-536) in Chinese Participants Who Require Regular Red Blood Cell Transfus Beta-thalassemia | Phase 2 | 2022-10-17 |
| Completed | Efficacy and Safety of Deucravacitinib Versus Placebo in Participants With Moderate-to-severe Scalp Psoriasis Psoriasis | Phase 4 | 2022-10-06 |
| Terminated | A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Canc Advanced Solid Tumors, Non-small Cell Lung Cancer | Phase 1 / Phase 2 | 2022-10-04 |
| Completed | A Study to Assess BMS-986207 in Combination With Nivolumab and Ipilimumab as First-line Treatment for Particip Non-Small Cell Lung Cancer | Phase 2 | 2022-10-03 |
| Completed | A Taste Assessment of Iberdomide and Mezigdomide in Healthy Participants Healthy Participants | — | 2022-09-30 |
| Recruiting | A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaq Psoriasis | — | 2022-09-30 |
| Completed | A Study to Assess the Safety and Tolerability of BMS-986322 in Healthy Participants of Japanese Descent Healthy Participants | Phase 1 | 2022-09-28 |
| Terminated | A Study to Evaluate the Safety and Tolerability of BMS-986403 in Participants With Relapsed and/or Refractory Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma | Phase 1 | 2022-09-14 |
| Terminated | A Phase 1, First-in-Human Study of BMS-986421 in Healthy Participants Healthy Participants | EARLY_Phase 1 | 2022-09-13 |
| Completed | A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolum Lymphoma, Non-Hodgkin, Hodgkin Disease | Phase 1 / Phase 2 | 2022-09-13 |
| Completed | A Study to Evaluate the Drug Exposure of Single Ascending Doses of BMS-986369 and the Effect of Food on the BM Healthy Volunteer | Phase 1 | 2022-09-12 |
| Completed | A Study to Assess the Effects of BMS-986371 on the Drug Levels of Methotrexate in the Presence and Absence of Healthy Participants | Phase 1 | 2022-09-06 |
| Completed | A Study of Mavacamten in Obstructive Hypertrophic Cardiomyopathy Cardiomyopathy, Hypertrophic Obstructive | Phase 3 | 2022-08-19 |
| Active Not Recruiting | An Efficacy and Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy in Chinese Participants With Leukemia, Myeloid, Acute | Phase 2 | 2022-08-19 |
| Recruiting | A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudina Obstructive Hypertrophic Cardiomyopathy | — | 2022-08-16 |
| Completed | A Study to Evaluate the Safety and Tolerability of BMS-986408 Alone and in Combination With Nivolumab or Nivol Advanced Solid Tumors | Phase 1 / Phase 2 | 2022-08-02 |
| Completed | A Study to Compare Nivolumab Administered Subcutaneously vs Intravenous in Melanoma Participants Following Com Melanoma | Phase 3 | 2022-08-02 |
| Active Not Recruiting | Real-World Outcomes in Relapsed/Refractory Multiple Myeloma Patients Treated, or Eligible for Treatment, With Multiple Myeloma | — | 2022-07-29 |
| Completed | Study of Relatlimab in Combination With Nivolumab in Chinese Participants Advanced Solid Tumors | Phase 1 | 2022-07-27 |
| Recruiting | A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring Multiple Sclerosis | — | 2022-07-15 |
| Completed | A Study to Evaluate the Safety, Tolerability, and Drug Levels of MYK-224 Administered in Single and Multiple D Healthy Volunteers | Phase 1 | 2022-07-12 |
| Active Not Recruiting | A Study of the Effectiveness and Safety of Nivolumab Plus Chemotherapy in Participants With Untreated Advanced Stomach Neoplasms | — | 2022-06-29 |
| Completed | A Study to Evaluate the Drug Levels of BMS-986166 in Healthy Male Participants Healthy Participants | Phase 1 | 2022-06-17 |
| Completed | A Study to Assess the Drug Levels of CC-92480 After Coadministration With Rifampin and Itraconazole, and the D Healthy Volunteers | Phase 1 | 2022-06-09 |
| Recruiting | Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion Mesothelioma, Non Small Cell Lung Cancer, Malignant Peripheral Nerve Sheath Tumors | Phase 1 | 2022-06-09 |
| Recruiting | A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerat Colitis, Ulcerative | Phase 2 / Phase 3 | 2022-05-30 |
| Terminated | A Study to Evaluate the Utilization, Effectiveness, and Quality of Life of Ozanimod in Participants With Ulcer Colitis, Ulcerative | — | 2022-05-30 |
| Completed | A Study to Evaluate the Effects on the Single-Dose Drug Levels of Mavacamten in Healthy Participants Healthy Participants | Phase 1 | 2022-05-16 |
| Completed | A Study to Compare the Drug Levels of Atazanavir and Cobicistat Between the Coadministration of Age-Appropriat Healthy Participants | Phase 1 | 2022-05-13 |
| Completed | A Study to Evaluate the Drug Levels of [14C]CC-99677 in Healthy Male Participants Healthy Volunteers | Phase 1 | 2022-05-12 |
| Completed | A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver Cancer Carcinoma, Hepatocellular | Phase 1 / Phase 2 | 2022-05-05 |
| Completed | A Study to Evaluate the Drug Levels of Cendakimab Delivered Subcutaneously in Healthy Participants Healthy Volunteers | Phase 1 | 2022-05-02 |
| Terminated | A Study of Nivolumab-relatlimab Fixed-dose Combination Versus Regorafenib or TAS-102 in Participants With Late Colorectal Neoplasms | Phase 3 | 2022-04-28 |
| Completed | A Study to Assess the Drug Interaction Between MYK-224 and Itraconazole and Verapamil in Healthy Participants Healthy Participants | Phase 1 | 2022-04-21 |
| Completed | A Study to Evaluate the Effect of Activated Charcoal With Sorbitol on the Single-dose of Mavacamten in Healthy Healthy Participants | Phase 1 | 2022-04-15 |
| Completed | A Study to Assess Relative Bioavailability of Branebrutinib, From a Tablet Formulation to the Capsule Formulat Healthy Volunteers | Phase 1 | 2022-04-08 |
| Completed | A Study of BMS-986406 as Monotherapy and Combination Therapies in Participants With Advanced Tumors Advanced Cancer | Phase 1 | 2022-03-31 |
| Completed | A Study to Evaluate BMS-986141 Added on to Aspirin or Ticagrelor or the Combination, on Thrombus Formation in Coronary Artery Disease, Healthy Participants | Phase 2 | 2022-03-25 |
| Completed | A Study of Azacitidine in Participants With International Prognostic Scoring System (IPSS) Intermediate-2 and Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute | — | 2022-02-25 |
| Completed | A Study Assessing the Health-Related Quality of Life (HRQoL) in Participants With Relapsed and/or Refractory M Multiple Myeloma | — | 2022-02-22 |
| Active Not Recruiting | A Study of Nivolumab Plus Chemotherapy in First Line Treatment of Adult Participants With Advanced or Metastat Gastric Cancer | — | 2022-02-16 |
| Terminated | A Study of BMS-986218 or BMS-986218 Plus Nivolumab in Combination With Docetaxel in Participants With Metastat Prostatic Neoplasms, Castration-Resistant | Phase 2 | 2022-02-14 |
| Withdrawn | Postmarketing Study of Empliciti in Korean Patients With Multiple Myeloma Multiple Myeloma | — | 2022-01-31 |
| Completed | A Study to Evaluate Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin f Mesothelioma, Malignant | Phase 2 | 2022-01-25 |
| Terminated | A Study to Assess the Effect of CC-95251 in Participants With Acute Myeloid Leukemia and Myelodysplastic Syndr Leukemia, Myeloid, Acute, Myelodysplastic Syndromes | Phase 1 | 2022-01-19 |
| Active Not Recruiting | A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Best Supportiv Acute Myeloid Leukemia | Phase 2 | 2022-01-17 |
| Completed | A Study of Yervoy and Opdivo Combination Therapy in Participants With Unresectable Advanced/Recurrent Malignan Mesothelioma, Malignant | — | 2022-01-08 |
| Completed | A Study to Evaluate the Effect of Co-administration of Itraconazole or Diltiazem on the Single-dose of Danicam Healthy Participants | Phase 1 | 2021-12-15 |
| Terminated | A Study to Evaluate the Safety, Tolerability, Kinetics, Biodistribution and Repeatability of 11C-BMS-986196 Af Multiple Sclerosis (MS) | Phase 1 | 2021-12-10 |
| Terminated | A Study to Assess Safety of Relatlimab With Ipilimumab in Participants With Advanced Melanoma Who Progressed o Melanoma | Phase 1 | 2021-12-09 |
| Completed | A Study of Preferences for the First-Line Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer Carcinoma, Non-Small-Cell Lung | — | 2021-12-09 |
| Completed | A Study to Assess Relatlimab and Nivolumab Fixed-dose Combination in Chinese Participants With Advanced Solid Advanced Solid Tumors | Phase 1 / Phase 2 | 2021-11-30 |
| Terminated | A Study to Assess Adjuvant Immunotherapy With Nivolumab Plus Relatlimab Versus Nivolumab Alone After Complete Melanoma | Phase 3 | 2021-10-19 |
| Active Not Recruiting | A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Sys Systemic Lupus Erythematosus | Phase 2 | 2021-10-11 |
| Completed | Measuring the Treatment Preferences of Participants in Japan With Moderate-to-Severe Psoriasis (PsO) Using Dis Psoriasis | — | 2021-10-01 |
| Completed | A Study to Evaluate the Bioavailability of Fedratinib When Administered in Different Ways to Healthy Adult Par Healthy Volunteers | Phase 1 | 2021-09-21 |
| Active Not Recruiting | A Study to Compare the Response to Treatment With Abatacept vs Adalimumab, on Background Methotrexate, in Adul Rheumatoid Arthritis | Phase 3 | 2021-09-15 |
| Completed | Taste Assessment of Ozanimod Healthy Volunteers | Phase 1 | 2021-09-09 |
| Active Not Recruiting | A Post-Authorization, Long-term Study of Ozanimod Real-world Safety Multiple Sclerosis, Relapsing-Remitting | — | 2021-09-02 |
| Completed | A Study of BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic Dermatitis Dermatitis, Atopic | Phase 2 | 2021-08-17 |
| Completed | A Study of BMS-986416 With and Without Nivolumab in Select Solid Tumors Advanced Solid Tumors | Phase 1 | 2021-08-09 |
| Completed | A Study to Characterize the Drug Levels of an Oral Contraceptive With and Without BMS-986166 in Healthy Female Healthy Participants | Phase 1 | 2021-08-03 |
| Completed | A Study to Assess Real-World Patient-Reported Outcomes With Fedratinib for Myelofibrosis Post-Ruxolitinib Myelofibrosis | — | 2021-08-02 |
| Completed | A Study to Assess the Effect of Itraconazole, Phenytoin and Gemfibrozil on the Drug Levels of BMS-986166 in He Healthy Participants | Phase 1 | 2021-07-28 |
| Recruiting | A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients A Renal Allograft Recipients | Phase 3 | 2021-07-21 |
| Completed | A Study to Evaluate the Drug Levels of Deucravacitinib From Tablets After Oral Administration in Healthy Parti Healthy Participants | Phase 1 | 2021-07-20 |
| Completed | A Study of Milvexian Using an IV Microtracer With Additional Formulation and Food Effect Comparison in Healthy Healthy Volunteers | Phase 1 | 2021-07-16 |
| Completed | A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986166 in Healthy Japanese Healthy Volunteers | Phase 1 | 2021-07-15 |
| Active Not Recruiting | A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Act Psoriatic Arthritis | Phase 3 | 2021-07-15 |
| Active Not Recruiting | A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Act Psoriatic Arthritis | Phase 3 | 2021-07-13 |
| Active Not Recruiting | A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Active Discoid and/or Subacute Lupus Erythematosus, Discoid, Lupus Erythematosus, Subacute Cutaneous | Phase 2 | 2021-07-12 |
| Completed | A Study to Determine the Effect of Famotidine on the Drug Levels of BMS-986256 in Healthy Participants Healthy Participants | Phase 1 | 2021-06-25 |
| Completed | A Study of Treatment Patterns and Clinical Outcomes of Psoriasis in Japan Psoriasis | — | 2021-06-25 |
| Withdrawn | A Study to Evaluate the Drug Levels and Safety of Pegbelfermin in Healthy Overweight and Obese Chinese and Kor Healthy Participants | Phase 1 | 2021-06-21 |
| Completed | A Study to Assess the Safety, Tolerability and Drug Levels of BMS-986172 in Healthy and Obese Participants, In Healthy Participants | Phase 1 | 2021-06-15 |
| Terminated | A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and You Ependymoma, Ewing Sarcoma, High-grade Glioma | Phase 1 / Phase 2 | 2021-06-03 |
| Completed | A Study Evaluating Quality of Life for Participants With Atrial Fibrillation (AF) Following a Bleed (EQUAL-AF) Atrial Fibrillation | — | 2021-05-31 |
| Completed | A Study to Assess Safety of Nivolumab in Routine Oncology Practice in China Non-Small Cell Lung Cancer, Squamous Cell Carcinoma of Head and Neck | — | 2021-05-28 |
| Completed | A Study to Determine the Safety, Drug Levels and Drug Effects of BMS-986196 and Food and Formulation Effects o Healthy Participants | Phase 1 | 2021-05-27 |
| Recruiting | A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advan Cervical Cancer, Gastric/Gastroesophageal Junction Adenocarcinoma, Microsatellite Stable Colorectal Cancer | Phase 1 / Phase 2 | 2021-05-27 |
| Active Not Recruiting | A Study of Subcutaneous Nivolumab Versus Intravenous Nivolumab in Participants With Previously Treated Clear C Clear Cell Renal Cell Carcinoma | Phase 3 | 2021-05-21 |
| Completed | A Study to Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease Crohn Disease, Ulcerative Colitis | Phase 2 | 2021-05-07 |
| Withdrawn | A Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Advanced Non-small Cell Lung Canc Carcinoma, Non-small Cell Lung Cancer | Phase 1 / Phase 2 | 2021-04-15 |
| Completed | A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986308 in Healthy Participa Healthy Participants | Phase 1 | 2021-04-14 |
| Completed | A Study of Participants With Non-Valvular Atrial Fibrillation (NVAF) Treated or Untreated With Oral Anticoagul Non-Valvular Atrial Fibrillation (NVAF) | — | 2021-04-02 |
| Withdrawn | A Study to Evaluate the Effect of Fluconazole, Bupropion, or Itraconazole on the Drug Levels and Safety of BMS Healthy Participants | Phase 1 | 2021-04-01 |
| Withdrawn | Neoadjuvant Nivolumab+Ipilimumab Followed by Adjuvant Nivolumab or Neoadjuvant Nivolumab+Ipilimumab Followed b Melanoma | Phase 2 | 2021-03-31 |
| Completed | A Study of Mavacamten in Participants With HFpEF and Elevation of NT-proBNP With or Without Elevation of cTnT Heart Failure With Preserved Ejection Fraction | Phase 2 | 2021-03-30 |
| Recruiting | A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Pediatric Participants With Mod Plaque Psoriasis | Phase 3 | 2021-03-23 |
| Active Not Recruiting | A Study to Assess the Safety and Tolerability of BMS-986158 Alone and in Combination With Either Ruxolitinib o Myelofibrosis | Phase 1 / Phase 2 | 2021-03-22 |
| Terminated | Safety and Effectiveness of BMS-986263 in Adults With Compensated Cirrhosis (Liver Disease) From Nonalcoholic Nonalcoholic Steatohepatitis (NASH) | Phase 2 | 2021-03-17 |
| Active Not Recruiting | A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Exten Extensive-stage Small Cell Lung Cancer | Phase 2 | 2021-03-17 |
| Active Not Recruiting | A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Multiple Sclerosis and Thei Multiple Sclerosis | — | 2021-03-16 |
| Completed | A Study of the Safety, Efficacy, and Biomarker Response of BMS-986165 in Participants With Moderate to Severe Colitis, Ulcerative | Phase 2 | 2021-03-15 |
| Completed | A Study Investigating the Utilization, Effectiveness and Quality of Life in Clinical Practice in Germany for P Multiple Sclerosis, Relapsing-Remitting | — | 2021-03-03 |
| Completed | A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986326 in Healthy Participa Healthy Participants | Phase 1 | 2021-03-03 |
| Terminated | A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-963272 in Participants With Nonalcoholic Nonalcoholic Fatty Liver Disease | Phase 1 | 2021-02-24 |
| Active Not Recruiting | A Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemot Non-small Cell Lung Cancer, Recurrent Non-small Cell Lung Cancer, Metastatic Non-small Cell Lung Cancer | Phase 2 | 2021-02-17 |
| Terminated | BMS-986325 in Healthy Participants and Participants With Primary Sjögren's Syndrome Healthy Participants, Primary Sjögren's Syndrome | Phase 1 | 2021-02-16 |
| Completed | A Study of Relatlimab in Combination With Nivolumab in Participants With Advanced Liver Cancer Who Have Never Hepatocellular Carcinoma, Hepatoma, Liver Cancer, Adult | Phase 2 | 2021-02-04 |
| Withdrawn | An Investigational Immuno-therapy Study of Nivolumab Given After Surgery in Non-Small Cell Lung Cancer (NSCLC) Non-Small Cell Lung Cancer, Non-Small-Cell Lung Carcinoma, Circulating Tumor DNA | Phase 2 | 2021-01-15 |
| Completed | A Study of Adjuvant Melanoma Stakeholder Treatment Preferences Melanoma | — | 2021-01-07 |
| Active Not Recruiting | A Study in Participants With First-Line Nivolumab Plus Ipilimumb Therapy Combined With Two Cycles of Chemother Carcinoma, Non-Small-Cell Lung | — | 2020-12-22 |
| Completed | Effect of BMS-986165 on the Blood Levels of Metformin Healthy Participants | Phase 1 | 2020-12-18 |
| Completed | A Study to Evaluate the Safety and Efficacy of Nivolumab With Ipilimumab in Participants With Untreated Advanc Kidney Neoplasms | Phase 4 | 2020-12-17 |
| Active Not Recruiting | A Study of Effectiveness and Safety of the First-Line Nivolumab Plus Ipilimumab With or Without Chemotherapy f Non-Small Cell Lung Cancer | — | 2020-12-15 |
| Completed | A Study to Evaluate the Drug Levels, Safety, and Tolerability of BMS-986036 in Participants With Normal Liver Moderate Liver Impairment, Severe Liver Impairment | Phase 1 | 2020-11-23 |
| Completed | Study of the Safety of BMS-986259 in Participants With Post-Acute Decompensated Heart Failure Acute Decompensated Heart Failure | Phase 2 | 2020-11-06 |
| Completed | Study to Assess the Way the Body Absorbs, Distributes, Breaks Down and Eliminates Radioactive BMS-986278 in He Healthy Volunteers | Phase 1 | 2020-10-15 |
| Terminated | Study of Abatacept in the Treatment of Hospitalized COVID-19 Participants With Respiratory Compromise COVID-19, SARS-CoV-2 | Phase 2 | 2020-10-14 |
| Active Not Recruiting | A Study of Fedratinib in Japanese Subjects With DIPSS (Dynamic International Prognostic Scoring System)- Inter Primary Myelofibrosis | Phase 1 / Phase 2 | 2020-10-12 |
| Completed | A Study of Nivolumab in Participants With Locally Advanced or Metastatic (Stage IIIB-IV) Non-Small Cell Lung C Non-Small Cell Lung Cancer | — | 2020-10-07 |
| Completed | A Study of Participants With Advanced Non-Small Cell Lung Cancer Treated With Nivolumab in France After at Lea Lung Cancer | — | 2020-09-28 |
| Completed | A Study of Multiple Immune and Disease Treatment Combinations in Participants With ER+HER2- Breast Cancer That Breast Cancer | Phase 1 | 2020-09-22 |
| Completed | A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986337 When Taken by Mouth by Healthy Par Healthy Volunteers | Phase 1 | 2020-09-17 |
| Completed | A Study of Nivolumab and Ipilimumab and Nivolumab Alone in Combination With Trans-arterial ChemoEmbolization ( Cancer, Hepatocellular | Phase 3 | 2020-09-14 |
| Completed | A Study to Compare Bempegaldesleukin (BEMPEG: NKTR-214) Combined With Nivolumab and Tyrosine Kinase Inhibitor Renal Cell Carcinoma | Phase 1 | 2020-09-11 |
| Completed | A Study to Evaluate the Drug Levels of BMS-986165 When Taken as Various Solid Tablet Prototypes by Healthy Par Healthy Volunteers | Phase 1 | 2020-09-10 |
| Terminated | A Study of Combination Nivolumab and Ipilimumab Retreatment in Patients With Advanced Renal Cell Carcinoma Renal Cell Carcinoma | Phase 2 | 2020-09-03 |
| Active Not Recruiting | A Prospective Non-Interventional Study in Participants Receiving Nivolumab in Adjuvant Setting for Resected Me Melanoma | — | 2020-09-02 |
| Completed | A Study to Compare the Taste and Levels in Blood Plasma of BMS-986165 When Taken as Different Formulations by Healthy Participants | Phase 1 | 2020-08-31 |
| Completed | A Study to Assess the Safety and Drug Levels of BMS-986256 in Participants With Active Cutaneous Lupus Erythem Lupus Erythematosus, Cutaneous | Phase 1 | 2020-08-26 |
| Completed | A Study of Anticoagulation Treatment Patterns and Outcomes of Participants Hospitalized With Coronavirus Disea COVID-19 | — | 2020-08-17 |
| Completed | A Study of Nivolumab in Participants With Squamous Cell Carcinoma of the Head & Neck (SCCHN) - Patient Reporte Squamous Cell Carcinoma of the Head and Neck | — | 2020-08-13 |
| Terminated | Exploratory Study of Danicamtiv in Patients With Primary Dilated Cardiomyopathy (DCM) Due to Genetic Variants Primary Familial Dilated Cardiomyopathy | Phase 2 | 2020-08-04 |
| Completed | Study to Assess the Effect of Branebrutinib on the Drug Levels of Rosuvastatin in Healthy Participants Healthy Participants | Phase 1 | 2020-08-02 |
| Completed | Relative Levels of BMS-986036 in Blood Plasma in Healthy, Overweight, and Obese Participants Following Subcuta Healthy Participants | Phase 1 | 2020-07-29 |
| Completed | A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis Pulmonary Fibrosis | Phase 2 | 2020-07-29 |
| Completed | Study to Assess the Effect of Acid-reducing Agent Famotidine on the Drug Levels of BMS-986256 in Healthy Parti Healthy Participants | Phase 1 | 2020-07-20 |
| Completed | Study of BMS-986315 Alone and in Combination With Nivolumab or Cetuximab in Participants With Advanced Solid T Advanced Solid Tumor | Phase 1 / Phase 2 | 2020-07-14 |
| Completed | A Study to Assess the Levels in Blood Plasma of BMS-986278 in Healthy Participants Following Administration of Healthy Participants | Phase 1 | 2020-07-10 |
| Recruiting | A Study Evaluating the Associations Between Clinical Characteristics and Use of Oral Anticoagulants in Italian Non-Valvular Atrial Fibrillation (NVAF) | — | 2020-07-09 |
| Completed | Participant Reported Outcomes and Treatment Experiences in Kidney Cancer Kidney Cancer | — | 2020-07-06 |
| Completed | A Study to Evaluate Mavacamten in Adults With Symptomatic Obstructive HCM Who Are Eligible for Septal Reductio HOCM, Hypertrophic Obstructive Cardiomyopathy | Phase 3 | 2020-07-06 |
| Terminated | A Study Evaluating the Drug Levels of Iplimumab Given Under the Skin Alone and in Combination With Nivolumab i Tumor | Phase 1 | 2020-06-25 |
| Completed | A Study of Participants With Squamous Cell Oesophageal Carcinoma Receiving Nivolumab as Part of an Early Acces Esophageal Squamous Cell Carcinoma | — | 2020-06-25 |
| Completed | Study to Evaluate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986331 in Healthy Participants Healthy Participants | Phase 1 | 2020-06-23 |
| Withdrawn | Study to Evaluate the Effect of Rifampin on the Drug Levels in Blood and Safety of BMS-986235 in Healthy Parti Healthy Participants | Phase 1 | 2020-03-09 |
| Completed | A Study to Evaluate the Pharmacokinetics (Drug Levels and Metabolism), Safety, and Tolerability of BMS-986259 Renal Failure | Phase 1 | 2020-02-26 |
| Completed | A Study to Examine the Acceptable Taste and to Estimate the Amount of Atazanavir and Cobicistat in the Body Wh Healthy Participants | Phase 1 | 2020-02-26 |
| Completed | Study to Assess the Way the Body Absorbs, Distributes, Breaks Down and Eliminates Radioactive BMS-986256 in He Healthy Participants | Phase 1 | 2020-02-18 |
| Completed | Pharmacokinetics (Drug Levels in Blood) of BMS-986165 When Taken as Various Solid Tablet Prototypes by Healthy Healthy Participants | Phase 1 | 2020-02-06 |
| Completed | A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prosta Prostate Cancer | Phase 3 | 2020-02-06 |
| Completed | A Study of Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Partic Bladder Cancer, Bladder Tumor, Muscle-Invasive Bladder Cancer | Phase 3 | 2020-02-05 |
| Completed | A Single-dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-986263 in Participants W Hepatic Impairment | Phase 1 | 2020-01-16 |
| Terminated | A Study Comparing the Efficacy and Safety of Nivolumab in Combination With Bacillus Calmette-Guerin (BCG) Vers Urinary Bladder Neoplasms | Phase 3 | 2020-01-15 |
| Completed | Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Autoimmune Disorder, Rheumatoid Arthritis, Systemic Lupus Erythematosus | Phase 2 | 2020-01-07 |
| Completed | A Study Comparing the Effects of Famotidine Pretreatment and of Food on the Relative Bioavailability of BMS-98 Healthy Participants | Phase 1 | 2019-12-27 |
| Completed | A Study of Treatment Patterns and Outcomes in Participants With Stage IIIA Melanoma Receiving Adjuvant Systemi Melanoma | — | 2019-12-19 |
| Completed | A Study to Determine if Identification of Undiagnosed Atrial Fibrillation in People at Least 70 Years of Age R Atrial Fibrillation, Atrial Flutter | Phase 4 | 2019-12-17 |
| Completed | An Observational Study of Adjuvant (Post-surgery) Therapy With Nivolumab for Resected (Completely Removed) Mel Melanoma | — | 2019-12-12 |
| Completed | A Study to Evaluate the Safety, Tolerability, Drug Levels and Drug Effects of Single and Multiple Doses of BMS Health Participants | Phase 1 | 2019-12-06 |
| Completed | An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo in Participants Wi Psoriasis | Phase 3 | 2019-11-25 |
| Completed | Study of Nivolumab Versus Placebo in Combination With Neoadjuvant Chemotherapy and Adjuvant Endocrine Therapy Breast Cancer | Phase 3 | 2019-11-18 |
| Completed | A Study Assessing the Drug Levels, Drug Effects, and Safety of BMS-986322 in Healthy Participants Healthy Participants | Phase 1 | 2019-11-15 |
| Active Not Recruiting | A Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by S Carcinoma, Non-Small-Cell Lung | Phase 3 | 2019-11-05 |
| Withdrawn | An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Ther Gastric Cancer, Cancer of the Stomach, Stomach Cancer | Phase 2 | 2019-10-31 |
| Active Not Recruiting | Effectiveness Study of Nivolumab Compared to Placebo in Prevention of Recurrent Melanoma After Complete Resect Melanoma | Phase 3 | 2019-10-28 |
| Completed | A Study of Neoadjuvant Nivolumab + Palbociclib + Anastrozole in Post-Menopausal Women and Men With Primary Bre Breast Cancer, Cancer | Phase 2 | 2019-10-18 |
| Completed | A Study of Nivolumab and Ipilimumab in Untreated Participants With Stage 3 Non-small Cell Lung Cancer (NSCLC) Non-Small Cell Lung Cancer (NSCLC) | Phase 3 | 2019-10-08 |
| Completed | A Study to Assess the Drug-drug Interaction of BMS-963272 and Rosuvastatin Healthy Participants | Phase 1 | 2019-10-08 |
| Completed | A Phase 1, Bioavailability Study of Relatlimab in Combination With Nivolumab Cancer | Phase 1 | 2019-10-01 |
| Completed | The Effects Diflunisal on the Levels of BMS-986165 in Healthy Participants Healthy Participants | Phase 1 | 2019-10-01 |
| Completed | A Study to Evaluate the Safety, Tolerability, Kinetics and Repeatability of 18F-BMS-986327 Healthy Participants, Idiopathic Pulmonary Fibrosis (IPF) | Phase 1 | 2019-10-01 |
| Active Not Recruiting | A Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Hepatocellular Carcinoma Hepatocellular Carcinoma | Phase 3 | 2019-09-30 |
| Completed | A Multiple Dose Study to Assess the Safety and Tolerability of BMS-963272 in Obese But Otherwise Healthy Adult Obese But Otherwise Healthy Participants | Phase 1 | 2019-09-30 |
| Completed | A Study of Nivolumab Plus Ipilimumab in Participants With Renal Cell Cancer in the Real World Setting in Japan Advanced or Metastatic Renal Cell Carcinoma | — | 2019-09-19 |
| Completed | A Study to Assess 7/8 HLA-matched Hematopoietic Stem Cell Transplantation Participants Treated With or Without Stem Cell Transplantation | — | 2019-09-16 |
| Completed | An Investigational Study to Determine the Drug Level Profile of BMS-986165 in Healthy Male Volunteers Followin Healthy Male Volunteers | Phase 1 | 2019-09-12 |
| Completed | An Investigational Immunotherapy Study of BMS-986288 Alone and in Combination With Nivolumab in Advanced Solid Advanced Cancer | Phase 1 / Phase 2 | 2019-09-06 |
| Completed | A Study to Determine the Pharmacokinetic Profile of BMS-986165 Tablets Lupus | Phase 1 | 2019-08-22 |
| Completed | A Study to Investigate the Effects of Cytochrome P450 1A2 Induction by Ritonavir on BMS-986165 Drug Levels and Healthy Participants | Phase 1 | 2019-08-14 |
| Active Not Recruiting | Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Pso Psoriasis | Phase 3 | 2019-08-12 |
| Active Not Recruiting | A Retrospective Observational Study on the Long-term Effects of Ipilimumab-treated Pediatric Participants in t Melanoma | — | 2019-08-12 |
| Recruiting | Pan Tumor Rollover Study Cancer | Phase 2 | 2019-08-09 |
| Completed | A Study of Preferences of Participants and Oncologists for the Characteristics of the Treatment for Renal Cell Renal Cell Carcinoma | — | 2019-08-05 |
| Active Not Recruiting | A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Pa Metastatic Colorectal Cancer | Phase 3 | 2019-08-05 |
| Completed | A Study Measuring the Effectiveness of BMS-986256 Combined With Oral Contraceptive in Healthy Female Participa Healthy Participants | Phase 1 | 2019-08-05 |
| Completed | Effects of BMS-986256 at Steady State on the Single Dose Pharmacokinetics of Mycophenolate Mofetil Healthy Participants | Phase 1 | 2019-07-22 |
| Withdrawn | A Single and Multiple Ascending Dose Study of BMS-986318 in Healthy Participants Healthy Participants | Phase 1 | 2019-07-18 |
| Terminated | An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in P Lupus Nephritis | Phase 2 | 2019-07-15 |
| Completed | A Post-marketing Study to Assess the Safety of Abatacept in Sweden Using the Swedish Rheumatology Quality Regi Rheumatoid Arthritis, Psoriatic Arthritis | — | 2019-07-01 |
| Completed | Safety and Efficacy of Deucravacitinib in Participants With Moderate to Severe Ulcerative Colitis Ulcerative Colitis | Phase 2 | 2019-07-01 |
| Completed | A Study to Assess the Effectiveness of an Atrial Fibrillation (AF) Risk Prediction Algorithm and Diagnostic Te Atrial Fibrillation | — | 2019-06-30 |
| Completed | A Study of Nivolumab in Patients With Head and Neck Cancer. Squamous Cell Carcinoma of the Head and Neck; Head and Neck Cancer; Head and Neck Carcinoma; Cancer of the Head and Neck | — | 2019-06-26 |
| Completed | A Study to Compare Nivolumab Drug Product Process D to Nivolumab Drug Product Process C in Participants With S Melanoma | Phase 1 | 2019-06-24 |
| Active Not Recruiting | A Study of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Participants With Advanced Kidney Canc Renal Cell Carcinoma | Phase 3 | 2019-06-21 |
| Completed | An Ascending Dose Study of BMS-986259 to Study Safety in Healthy Participants Healthy Participants | Phase 1 | 2019-06-18 |
| Completed | A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA) | — | 2019-06-13 |
| Completed | A Study to Investigate the Effects of Gastric Acid Suppression by Rabeprazole and BMS-986165 on How Fast and C Healthy | Phase 1 | 2019-05-16 |
| Completed | A Study of the Pharmacokinetic Interaction Between Pirfenidone and BMS-986278 in Healthy Participants Idiopathic Pulmonary Fibrosis (IPF) | Phase 1 | 2019-05-10 |
| Completed | A Study to Evaluate the Effect of Omeprazole on the Pharmacokinetics of BMS-986205 in Healthy Participants Healthy | Phase 1 | 2019-05-08 |
| Completed | Pharmacokinetic and Metabolism of [14^C] BMS-986177 in Healthy Male Participants Thrombosis | Phase 1 | 2019-05-02 |
| Completed | A Study to Investigate the Effects of Itraconazole on the Pharmacokinetics of BMS-986256 in Healthy Participan Healthy Participants | Phase 1 | 2019-05-02 |
| Completed | Study to Characterize the Effects of Cytochrome p450 1A2 Inhibition on Systemic Exposure to BMS-986165 Healthy | Phase 1 | 2019-05-01 |
| Completed | An Investigational Study to Evaluate Experimental Medication BMS-986165 in Japanese Participants With Moderate Psoriasis | Phase 3 | 2019-04-10 |
| Completed | An Investigational Study of NKTR-214 Combined With Nivolumab in Japanese Participants With Advanced Solid Tumo Advanced Cancer | Phase 1 | 2019-04-09 |
| Completed | Single and Multiple Dose Pharmacokinetics of BMS-986165 in a Randomized, Double-Blind, Placebo-Controlled Stud Autoimmune Diseases | Phase 1 | 2019-04-04 |
| Completed | A Study to Assess the Safety of Experimental Medication BMS986165 in Participants With Normal Kidney Function Renal Impairment, Healthy Volunteer | Phase 1 | 2019-04-04 |
| Completed | Efficacy and Safety of BMS-986165 Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Active Psoriatic Arthritis | Phase 2 | 2019-04-01 |
| Completed | An Investigational Immunotherapy Study of BMS-986301 Alone or in Combination With Nivolumab, and Ipilimumab in Advanced Solid Cancers | Phase 1 | 2019-03-26 |
| Completed | Long-Term Safety and Efficacy Study of Deucravacitinib in Participants With Systemic Lupus Erythematosus Systemic Lupus Erythematosus | Phase 2 | 2019-03-26 |
| Completed | A Pharmacokinetics, Safety and Tolerability Study of Multiple Formulations of BMS-986231 in Healthy Participan Heart Failure | Phase 1 | 2019-02-28 |
| Completed | An Investigational Study of BMS-986165 in Participants With Normal Liver Function and Participants With Mild t Liver Dysfunction, Healthy Volunteers | Phase 1 | 2019-02-26 |
| Completed | A Study of Overall Survival in Participants With Metastatic Colorectal Cancer (mCRC) Metastatic Colorectal Cancer (mCRC) | — | 2019-01-28 |
| Completed | A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel Acute Ischemic Stroke, Transient Ischemic Attack (TIA) | Phase 2 | 2019-01-27 |
| Completed | Assessment of Gut Absorption of Experimental Medication BMS-986165 in Healthy Males Psoriasis | Phase 1 | 2019-01-25 |
| Completed | An Investigational Study of Continuous 8-Hour Intravenous Administrations of BMS-986231 in Participants With H Cardiac Failure, Myocardial Failure, Congestive Heart Failure | Phase 2 | 2019-01-17 |
| Unknown | A Study of Patients Receiving Adjuvant Nivolumab Therapy for Melanoma That Has Been Removed Melanoma | — | 2019-01-16 |
| Completed | Treatment Patterns and Outcomes in Participants With Advanced Melanoma in Germany Using a German Database Advanced Melanoma | — | 2019-01-09 |
| Completed | A Study is to Understand the Treatment Patterns for Immunotherapy Agents and BRAF/MEK Inhibitors Used in the T Melanoma | — | 2019-01-09 |
| Completed | A Trial of AVID200, a Transforming Growth Factor β (TGFβ) Inhibitor, in Patients Malignancies Malignant Solid Tumor | Phase 1 | 2019-01-07 |
| Completed | A Study of Treatment Patterns and Clinical Outcomes in First Line Recurrent/Metastatic Squamous Cell Carcinoma Squamous Cell Carcinoma of the Head and Neck | — | 2019-01-01 |
| Completed | Safety and Tolerability Study of AVID200 in Pts With Diffuse Cutaneous Systemic Sclerosis Scleroderma, Diffuse | Phase 1 | 2019-01-01 |
| Completed | A Study of BMS-986205 Alone and in Combination With Nivolumab in Chinese Patients With Advanced Malignant Soli Advanced Cancer | Phase 1 / Phase 2 | 2018-12-31 |
| Completed | An Investigational Study to Evaluate Experimental Medication BMS-986165 Given as a Tablet and Solution in Heal Healthy Participants | Phase 1 | 2018-12-05 |
| Withdrawn | Early Post-marketing Study of Daclatasvir (Daklinza®) + Asunaprevir (Sunvepra®) in the Treatment of Chronic He Hepatitis C | — | 2018-11-30 |
| Completed | A Study to Evaluate the Pharmacokinetics of Abatacept Converted From Drug Substance by Two Different Processes Rheumatoid Arthritis | Phase 1 | 2018-11-09 |
| Active Not Recruiting | A Study to Compare Chemotherapy Alone Versus Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205, Followed Urinary Bladder Neoplasms, Muscle-Invasive Bladder Cancer | Phase 3 | 2018-11-06 |
| Completed | A Study of Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Soli Pan Tumor | Phase 2 | 2018-10-31 |
| Completed | A Study to Assess Overall Survival and Treatment Patterns for Advanced Liver Cancer Participants Who Received Hepatocellular Carcinoma | — | 2018-10-29 |
| Completed | A Study of Subcutaneous Nivolumab Monotherapy With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20) Neoplasms by Site | Phase 1 / Phase 2 | 2018-10-29 |
| Completed | An Investigational Study of Immunotherapy Combinations With Chemotherapy in Patients With Gastric or Gastroeso Gastric Cancer, Cancer of the Stomach, Esophagogastric Junction | Phase 2 | 2018-10-16 |
| Completed | A Taste Assessment of BMS-986165 in Healthy Participants Healthy Participants | Phase 1 | 2018-10-11 |
| Completed | A Study to Assess Administration of an Oral Anti-thrombotic With Antiplatelet Therapy in Healthy Subjects Healthy Volunteers | Phase 1 | 2018-10-04 |
| Completed | A Study of Participants in Australia Who Have Non-small Cell Lung Cancer Being Treated With Nivolumab Non-Small Cell Lung Cancer | — | 2018-10-03 |
| Completed | A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM Hypertrophic Cardiomyopathy, Obstructive Hypertrophic Cardiomyopathy, Non-obstructive Hypertrophic Cardiomyopathy | Phase 2 / Phase 3 | 2018-09-27 |
| Completed | Evaluation of Safety and Effectiveness on Oral Anticoagulants Atrial Fibrillation | — | 2018-09-21 |
| Completed | A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inope Melanoma | Phase 3 | 2018-09-21 |
| Completed | A Study to Observe the Onset of Immune-related Adverse Reactions in Patients With Non-surgical or Renal Cell C Renal Cell Carcinoma, Kidney Cancer | — | 2018-09-18 |
| Completed | An Investigational Immunotherapy Study of BMS-986310 Administered Alone and in Combination With Nivolumab in P Advanced Cancer | Phase 1 | 2018-09-11 |
| Completed | An Investigational Study to Evaluate Experimental Medication BMS-986036 in Participants With Different Levels NAFLD, Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis | Phase 1 | 2018-09-11 |
| Completed | An Investigational Study of Experimental Medication BMS-986278 Given With the Antibiotic Rifampin in Healthy P Healthy Participants | Phase 1 | 2018-09-06 |
| Completed | An Investigational Study of Experimental Medication BMS-986165 in Healthy Participants Healthy Participants | Phase 1 | 2018-08-14 |
| Completed | An Investigational Study to Evaluate the Effects of Experimental Medication BMS-986256 in Healthy Participants Healthy Participants | Phase 1 | 2018-08-14 |
| Completed | An Investigational Study to Evaluate Experimental Medication BMS-986224 in Renally Impaired Participants Cardiac Failure, Myocardial Failure | Phase 1 | 2018-08-14 |
| Completed | Effectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With Psoriasi Psoriasis | Phase 3 | 2018-08-07 |
| Terminated | A Study of Nivolumab or Nivolumab Plus Experimental Medication BMS-986205 With or Without Bacillus Calumette-G Urinary Bladder Neoplasms | Phase 2 | 2018-08-02 |
| Completed | A Comparison of Nivolumab-based Treatments in a Real-world PD-L1 Positive Metastatic Melanoma Population in th Melanoma | — | 2018-07-31 |
| Completed | An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Av Psoriasis | Phase 3 | 2018-07-26 |
| Terminated | An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Granulomatous Colitis, Crohn's Disease, Crohn's Enteritis | Phase 2 | 2018-07-16 |
| Terminated | Evaluation of Daclatasvir (DCV) in Combination With Sofosbuvir (SOF) in Children With Chronic Hepatitis C (CHC Hepatitis C, Chronic Hepatitis | Phase 2 | 2018-06-25 |
| Completed | A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 L Liver Fibrosis, Nonalcoholic Fatty Liver Disease (NAFLD), Nonalcoholic Steatohepatitis | Phase 2 | 2018-06-19 |
| Completed | A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cir Hepatic Cirrhosis, Liver Fibrosis, Nonalcoholic Fatty Liver Disease (NAFLD) | Phase 2 | 2018-06-12 |
| Completed | An Investigational Study to Evaluate the Effect of Rifampin on the Singe Dose of Experimental Medication BMS-9 Healthy Participants | Phase 1 | 2018-06-01 |
| Completed | An Investigational Study of Experimental Medication BMS-986165 in Healthy Participants to Study Electrocardiog Systemic Lupus Erythematosus, Healthy Participants | Phase 1 | 2018-05-30 |
| Completed | An Investigational Study of Immunotherapy Combinations in Participants With Solid Cancers That Are Advanced or Advanced Cancer | Phase 1 / Phase 2 | 2018-05-30 |
| Completed | An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver Dysfunction, Liver Insufficiency, Hepatic Failure | Phase 1 | 2018-05-25 |
| Withdrawn | An Immuno-Therapy Study of Experimental Medication BMS-986205 Given With Nivolumab With or Without Chemotherap Lung Cancer, Non-Small Cell Lung Cancer | Phase 3 | 2018-05-24 |
| Terminated | Study of Daclatasvir-based Therapy in Chinese Participants With Chronic Hepatitis C (CHC) Chronic Hepatitis C | — | 2018-05-08 |
| Completed | An Adaptive Study to Match Patients With Solid Tumors to Various Immunotherapy Combinations Based Upon a Broad Advanced Cancer | Phase 1 | 2018-05-07 |
| Completed | Study to Determine if the Flu Vaccine Increases the Risk of Muscle Damage in Participants Taking Drugs That Bl Cancer | — | 2018-05-02 |
| Completed | Extension Study of Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy Pre Hypertrophic Cardiomyopathy | Phase 2 | 2018-04-26 |
| Completed | Bioavailability of Apixaban Sprinkle Compared to Apixaban Capsules Healthy Volunteers | Phase 1 | 2018-04-26 |
| Active Not Recruiting | A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Cu Hepatocellular Carcinoma, Liver Cancer | Phase 3 | 2018-04-18 |
| Completed | A Study of Abatacept in Participants That Only Recently Started to Develop Rheumatoid Arthritis Rheumatoid Arthritis | — | 2018-04-17 |
| Active Not Recruiting | A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma Melanoma | Phase 2 / Phase 3 | 2018-04-11 |
| Completed | Study of the Safety of Orencia in Japanese Children and Adolescents With Active Juvenile Arthritis of Unknown Undifferentiated Arthritis | — | 2018-04-06 |
| Terminated | An Investigational Immunotherapy Study of BMS-986299 Alone and in Combination With Nivolumab and Ipilimumab in Advanced Cancer | Phase 1 | 2018-04-05 |
| Withdrawn | An Immuno-therapy Study of Nivolumab in Combination With Experimental Medication BMS-986205 Compared to Standa Head and Neck Cancer | Phase 3 | 2018-03-28 |
| Completed | A Study of Experimental Medication BMS-986231 in Patients With Different Levels of Kidney Function Myocardial Failure, Cardiac Failure, Congestive Heart Failure | Phase 1 | 2018-03-15 |
| Withdrawn | A Safety Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Non-small Cell Lung C Non-Small Cell Lung Cancer | Phase 3 | 2018-03-09 |
| Terminated | An Investigational Immunotherapy Study of BMS-986258 Alone and in Combination With Nivolumab in Participants W Advanced Cancer | Phase 1 / Phase 2 | 2018-03-08 |
| Completed | Study of Nivolumab for Advanced Cancers in India Non-Small Cell Lung Cancer (NSCLC), Non-Small-Cell Lung Carcinoma, Nonsmall Cell Lung Cancer | Phase 4 | 2018-03-06 |
| Completed | An Investigational Study of Cyclosporine on Experimental Medication BMS-986165 in Healthy Male Participants Psoriasis | Phase 1 | 2018-03-05 |